Table 1 Baseline characteristics of all MPM patients
Baseline characteristics | N = 184 |
|---|---|
Mean age in years (95% CI) | 72.4 (71.2–73.5) |
Male | 160 (87%) |
Stage at diagnosis | |
I | 60 (33%) |
II | 8 (4%) |
III | 73 (40%) |
IV | 37 (20%) |
Missing data | 6 (3%) |
WHO performance status | |
0 | 49 (27%) |
1 | 85 (46%) |
2 | 23 (13%) |
3 | 8 (4%) |
Not documented | 19 (10%) |
Mode of diagnosis | |
LAT | 92 (50%) |
CT guided | 52 (28%) |
VATS | 31 (17%) |
US guided | 9 (5%) |
Histological subtype | |
Epithelioid | 120 (65%) |
Sarcomatoid | 36 (20%) |
Biphasic | 15 (8%) |
Desmoplastic | 4 (2%) |
Mesothelioma NOS | 9 (5%) |
Treatment modality | |
Best supportive care (only) | 90 (49%) |
First line chemotherapy (only) | 84 (46%) |
Second line chemotherapy | 10 (5%) |
Surgery or radical radiotherapy | 0 (0%) |